Irinotecan plus raltitrexed as second-line treatment in locally advanced or metastatic colorectal cancer patients: a prospective open-label, single-arm, multi-center, phase II study.
Cheng Y, Teng Z, Zhang Y, Jin B, Zheng Z, Man L, Wang Z, Teng Y, Yu P, Shi J, Luo Y, Wang Y, Zhang J, Zhang H, Liu J, Chen H, Xiao J, Zhao L, Zhang L, Jiang Y, Chen Y, Zhang J, Wang C, Liu S, Qu J, Qu X, Liu Y.
Cheng Y, et al. Among authors: wang z, wang y, wang c.
BMC Cancer. 2024 Sep 2;24(1):1082. doi: 10.1186/s12885-024-12831-4.
BMC Cancer. 2024.
PMID: 39223545
Free PMC article.
Clinical Trial.